Formulations and methods for providing progestin-only...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/567 (2006.01) A61K 9/70 (2006.01) A61M 37/00 (2006.01) A61P 15/18 (2006.01)

Patent

CA 2624810

Formulations and methods for providing progestin-only contraception to a woman while minimizing various side effects, such as breakthrough bleeding, that are normally associated with progestin-only contraception are disclosed and described. In one aspect, the method can include transdermally administering a formulation having a contraceptively effective amount of a single progestin as the sole active hormonal agent to the woman as part of a contraceptive regimen.

La présente invention concerne des formules et méthodes pour fournir une contraception à la progestine uniquement tout en minimisant plusieurs effets secondaires indésirables, tels qu~un saignement profus, qui sont normalement associés à une contraception à la progestine uniquement. Selon un aspect, la méthode peut inclure l~administration transdermale à la femme d~une formule ayant une quantité contraceptivement efficace d'une progestine unique comme seul agent hormonal actif, dans le cadre d'un régime contraceptif.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Formulations and methods for providing progestin-only... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Formulations and methods for providing progestin-only..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulations and methods for providing progestin-only... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2085813

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.